Neuronetics to be Added to the Russell 2000®, 3000® and Microcap® Indexes MALVERN, Pa., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial-stage medical device company focused on designing, developing, and manufacturing products that improve...

Neuronetics Reports Second Quarter 2018 Financial and Operating Results MALVERN, Pa., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...

Neuronetics, Inc. to Report Second Quarter 2018 Financial Results and Host Conference Call MALVERN, Pa., July 31, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial-stage medical device company focused on designing, developing, and manufacturing products that improve...

Neuronetics, Inc., Maker of NeuroStar® Advanced Therapy, Announces Closing of Initial Public Offering and the Exercise in Full of the Underwriters’ Option to Purchase Additional Shares MALVERN, Pa., July 02, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc., a commercial-stage medical device company focused on designing, developing, and manufacturing products that improve the quality of...

Neuronetics, Inc., Maker of NeuroStar® Advanced Therapy, Announces Pricing of Initial Public Offering MALVERN, Pa., June 28, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc., a commercial-stage medical device company focused on designing, developing, and manufacturing products that improve the quality of...